Top Markets
Coin of the day
VectivBio Holding AG VectivBio Holding AG

VectivBio Holding AG

VECT
Kedudukan dalam Saham #14766
VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to... VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to identifying, developing, and commercializing treatments for severe rare medical conditions. The company's primary therapeutic focus is apraglutide, a prolonged-acting synthetic peptide analog of glucagon-like peptide-2. This compound is currently in a Phase III clinical trial for individuals with short bowel syndrome-intestinal failure (SBS-IF), and is also being evaluated in a Phase II clinical trial for SBS-IF patients with colon-in-continuity anatomy. Furthermore, apraglutide is undergoing a Phase II clinical study for patients experiencing steroid-refractory gastrointestinal acute graft-versus-host disease (aGvHD). Founded in 2019, VectivBio's corporate headquarters are situated in Basel, Switzerland.
Harga Saham
$16.85
Disegerakkan terakhir: 2023-07-07
Modal Pasaran
$393.50M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
CH
Perdagangan VectivBio Holding AG (VECT)

Kategori

Bilangan saham terbitan bagi VectivBio Holding AG (VECT)
Bilangan saham terbitan setakat September 2026: 0
Menurut laporan kewangan terkini dan harga saham VectivBio Holding AG, bilangan saham terbitan semasa ialah 0. Pada akhir September 2026, syarikat mempunyai 0 saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk VectivBio Holding AG (VECT) dari 2026 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
253.90M -
US
62.19M -
NL
478.91M -
AU
396.00M -
US
- -
CH